文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

大型队列中维生素D状态与全因及病因特异性死亡风险:英国生物银行结果

Vitamin D Status and Risk of All-Cause and Cause-Specific Mortality in a Large Cohort: Results From the UK Biobank.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

英国生物银行前瞻性队列纳入365530名基线无心血管疾病、癌症或糖尿病且测量了血清25(OH)D的参与者,中位随访8.9年发生10175例死亡。25(OH)D与全因、心血管疾病及癌症死亡呈非线性负相关,全因和心血管疾病死亡风险在60 nmol/L、癌症死亡在45 nmol/L后趋于平稳。

要点

  • 25(OH)D与全因、心血管疾病及癌症死亡呈非线性负相关。
  • 全因和心血管疾病死亡风险在25(OH)D达60 nmol/L后趋于平稳,癌症死亡在45 nmol/L后趋于平稳。
  • 高于切点者全因死亡风险降低17%(HR 0.83,95%CI 0.79-0.86)。

核心结论

  • 较高的25(OH)D浓度与较低的全因、心血管疾病和癌症死亡风险呈非线性相关。
  • 45至60 nmol/L的阈值可能代表降低总体早死风险的干预目标,需在大型临床试验中进一步确认。

研究设计与样本

  • 前瞻性队列研究,数据来自英国生物银行。
  • 纳入365530名基线(2006-2010年)有血清25(OH)D测量且无心血管疾病、癌症或糖尿病史的参与者。
  • 中位随访8.9年(四分位距8.3-9.5年)。

主要发现

  • 随访期间共发生10175例死亡,其中心血管疾病死亡1841例(18.1%),癌症死亡5737例(56.4%)。
  • 多变量分析显示非线性负相关,全因和心血管疾病死亡风险在25(OH)D达60 nmol/L后趋于平稳,癌症死亡在45 nmol/L后趋于平稳。
  • 与25(OH)D低于切点的参与者相比,高于切点者全因死亡风险降低17%(HR 0.83,95%CI 0.79-0.86)。
  • 与25(OH)D低于切点的参与者相比,高于切点者心血管疾病死亡风险降低23%(HR 0.77,95%CI 0.68-0.86)。
  • 与25(OH)D低于切点的参与者相比,高于切点者癌症死亡风险降低11%(HR 0.89,95%CI 0.84-0.95)。

关键数值与推荐

  • 全因和心血管疾病死亡风险在25(OH)D 60 nmol/L后趋于平稳。
  • 癌症死亡风险在25(OH)D 45 nmol/L后趋于平稳。
  • 45至60 nmol/L的阈值可能代表降低总体早死风险的干预目标,需在大型临床试验中进一步确认。

局限性

  • 45至60 nmol/L的阈值可能代表干预目标,需在大型临床试验中进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Although an inverse association between vitamin D status and mortality has been reported in observational studies, the precise association shape and optimal vitamin D status remain undetermined. OBJECTIVE: To investigate the association between vitamin D status and risk of all-cause and cause-specific mortality and estimate optimal serum 25-hydroxyvitamin D [25(OH)D] concentrations. DESIGN: Prospective cohort study. SETTING: UK Biobank. PARTICIPANTS: 365 530 participants who had serum 25(OH)D measurements and no history of cardiovascular disease (CVD), cancer, or diabetes at baseline (2006-2010). MAIN OUTCOME MEASURES: All-cause and cause-specific mortality. RESULTS: During a median follow-up of 8.9 (interquartile range: 8.3-9.5) years, 10 175 deaths occurred, including 1841 (18.1%) due to CVD and 5737 (56.4%) due to cancer. The multivariate analyses revealed nonlinear inverse associations, with a decrease in mortality risk appearing to level off at 60 nmol/L of 25(OH)D for all-cause and CVD deaths and at 45 nmol/L for cancer deaths. Compared to participants with 25(OH)D concentrations below the cutoffs, those with higher concentrations had a 17% lower risk for all-cause mortality (hazard ratio [HR]: 0.83, 95% confidence interval [CI]: 0.79-0.86), 23% lower risk for CVD mortality (HR: 0.77, 95% CI: 0.68-0.86), and 11% lower risk for cancer mortality (HR: 0.89, 95% CI: 0.84-0.95). CONCLUSIONS: Higher 25(OH)D concentrations are nonlinearly associated with lower risk of all-cause, CVD, and cancer mortality. The thresholds of 45 to 60 nmol/L might represent an intervention target to reduce the overall risk of premature death, which needs further confirmation in large clinical trials.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fan X, Wang J, Song M, et al. Vitamin D Status and Risk of All-Cause and Cause-Specific Mortality in a Large Cohort: Results From the UK Biobank. J Clin Endocrinol Metab. 2020. PMID: 32620963. doi:10.1210/clinem/dgaa432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。